# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Medium-chain acyl-coenzyme A dehydrogenase deficiency

MCAD Deficiency
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-9 of 9 results.
Fasting Tolerance in MCADD-infants
Status: Recruiting
Last Changed: May 14, 2019
First Received: Dec 03, 2018
Disease(s): Mcad Deficiency
Intervention(s): Fasting test
Locations: University Medical Center Groningen, Groningen, Netherlands
Use of Ravicti™ in Patients With MCAD Deficiency With the 985A>G (K304E) Mutation
Status: Completed
Last Changed: Sep 25, 2017
First Received: Jun 20, 2013
Disease(s): Medium-chain Acyl-CoA Dehydrogenase (MCAD) Deficiency
Intervention(s): Ravicti
Locations: Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
Fatty Acid Oxidation Defects and Insulin Sensitivity
Status: Recruiting
Last Changed: Jul 17, 2019
First Received: Aug 07, 2015
Disease(s): Very Long-chain Acyl-CoA Dehydrogenase Deficiency, Trifunctional Protein Deficiency, Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency, Medium-chain Acyl-CoA Dehydrogenase Deficiency, Normal Volunteers, Carnitine Palmitoyltransferase II Deficiency, Myopathic
Intervention(s): Intralipid/Heparin, Glycerol/Saline, Hyperinsulinemic euglycemic clamp
Locations: Oregon Health & Science University, Portland, Oregon, United States
Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy
Status: Active, not recruiting
Last Changed: Oct 16, 2019
First Received: Dec 18, 2015
Disease(s): Metabolism, Inborn Errors, Lipid Metabolism, Inborn Errors, Carbohydrate Metabolism, Inborn Errors, Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency, Glycogenin-1 Deficiency (Glycogen Storage Disease Type XV), Carnitine Palmitoyl Transferase 2 Deficiency, VLCAD Deficiency, Medium-chain Acyl-CoA Dehydrogenase Deficiency, Multiple Acyl-CoA Dehydrogenase Deficiency, Carnitine Transporter Deficiency, Neutral Lipid Storage Disease, Glycogen Storage Disease Type II, Glycogen Storage Disease Type III, Glycogen Storage Disease Type IV, Glycogen Storage Disease Type V, Muscle Phosphofructokinase Deficiency, Phosphoglucomutase 1 Deficiency, Phosphoglycerate Mutase Deficiency, Phosphoglycerate Kinase Deficiency, Phosphorylase Kinase Deficiency, Beta Enolase Deficiency, Lactate Dehydrogenase Deficiency, Glycogen Synthase Deficiency
Intervention(s): Sugar
Locations: Neuromuscular Research Unit, 3342, Copenhagen, Denmark
Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects
Status: Completed
Last Changed: May 30, 2012
First Received: Sep 24, 2009
Disease(s): Carnitine Palmitoyltransferase II Deficiency, Very Long Chain Acyl Coa Dehydrogenase Deficiency
Intervention(s): Bezafibrate, Placebo
Locations: Neuromusculare Research Unit, Rigshospitalet, Copenhagen, Denmark
High Protein Diet in Patients With Long-chain Fatty Acid Oxidation Disorders
Status: Completed
Last Changed: Dec 16, 2011
First Received: Dec 16, 2011
Disease(s): Very Long-chain Acyl-CoA Dehydrogenase Deficiency, Trifunctional Protein Deficiency, Carnitine Palmitoyltransferase 2 Deficiency, Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency
Intervention(s): Diet counseling
Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorder
Status: Completed
Last Changed: Mar 23, 2017
First Received: Jun 23, 2011
Disease(s): Very Long-chain acylCoA Dehydrogenase (VLCAD) Deficiency, Carnitine Palmitoyltransferase 2 (CPT2) Deficiency, Mitochondrial Trifunctional Protein (TFP) Deficiency, Long-chain 3 hydroxyacylCoA Dehydrogenase (LCHAD) Deficiency
Intervention(s): Triheptanoin
Locations: Oregon Health & Science University, Portland, Oregon, United States
University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies.
Status: Enrolling by invitation
Last Changed: Mar 04, 2020
First Received: Aug 12, 2014
Disease(s): Carnitine Palmitoyltransferase (CPT I or CPT II) Deficiency, Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, Long-chain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency, Trifunctional Protein (TFP) Deficiency, Carnitine-acylcarnitine Translocase (CACT) Deficiency
Intervention(s): UX007
Locations: University of California San Francisco, San Francisco, California, United States
Children's National Health System, Washington, District of Columbia, United States
University of South Florida, Tampa, Florida, United States
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Boston Children's Hospital, Boston, Massachusetts, United States
... and 7 other locations.
An Open-label Phase 2 Study of UX007 (Triheptanoin) in Subjects With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)
Status: Completed
Last Changed: Oct 25, 2019
First Received: Jun 25, 2013
Disease(s): Long-chain Fatty Acid Oxidation Disorders (LC-FAOD), Carnitine Palmitoyltransferase (CPT II) Deficiency, Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, Longchain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency, Trifunctional Protein (TFP) Deficiency
Intervention(s): UX007
Locations: Children's National Medical Center, Washington, District of Columbia, United States
University of Southern Florida, Tampa, Florida, United States
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Boston Children's Hospital, Boston, Massachusetts, United States
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
... and 6 other locations.